{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T21:47:03Z","timestamp":1769032023070,"version":"3.49.0"},"reference-count":23,"publisher":"e-Century Publishing Corporation","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/enom2926","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T03:31:02Z","timestamp":1749180662000},"page":"3813-3823","source":"Crossref","is-referenced-by-count":0,"title":["Cystic fibrosis caused by homozygous CFTR gene mutation leading to pulmonary involvement: a case report"],"prefix":"10.62347","volume":"17","author":[{"given":"Ji-Peng","family":"Duan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.medcli.2023.06.006","article-title":"Cystic fibrosis: epidemiology, clinical manifestations, diagnosis and treatment","volume":"161","author":"C&#xE1","year":"2023","unstructured":"Diab Cáceres L and Zamarrón de Lucas E. Cystic fibrosis: epidemiology, clinical manifestations, diagnosis and treatment. Med Clin (Barc) 2023; 161: 389-396.","journal-title":"Med Clin (Barc)"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1164\/rccm.200505-840OE","article-title":"Cystic fibrosis since 1938","volume":"173","author":"Davis","year":"2006","unstructured":"Davis PB. Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006; 173: 475-482.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","unstructured":"Elborn JS. Cystic fibrosis. Lancet 2016; 388: 2519-2531.","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.12998\/wjcc.v7.i15.2110","article-title":"753_754delAG, a novel CFTR mutation found in a Chinese patient with cystic fibrosis: a case report and review of the literature","volume":"7","author":"Wang","year":"2019","unstructured":"Wang YQ, Hao CL, Jiang WJ, Lu YH, Sun HQ, Gao CY and Wu M. c.753_754delAG, a novel CFTR mutation found in a Chinese patient with cystic fibrosis: a case report and review of the literature. World J Clin Cases 2019; 7: 2110-2119.","journal-title":"World J Clin Cases"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s11684-021-0846-5","article-title":"1210-3C>G in cis with a poly-T tract of 5T affects CFTR mRNA splicing in a Chinese patient with cystic fibrosis","volume":"16","author":"Zhao","year":"2022","unstructured":"Zhao X, Liu K, Xu W, Xiao M, Zhang Q, Song J, Chen K, Liu Y, Tian X, Xu KF and Zhang X. Novel mutation c.1210-3C>G in cis with a poly-T tract of 5T affects CFTR mRNA splicing in a Chinese patient with cystic fibrosis. Front Med 2022; 16: 150-155.","journal-title":"Front Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/00029330-200601020-00003","article-title":"A novel CFTR mutation found in a Chinese patient with cystic fibrosis","volume":"119","author":"Li","year":"2006","unstructured":"Li N, Pei P, Bu DF, He B and Wang GF. A novel CFTR mutation found in a Chinese patient with cystic fibrosis. Chin Med J (Engl) 2006; 119: 103-9.","journal-title":"Chin Med J (Engl)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/ppul.26601","article-title":"Clinical and genetic characteristics of children with cystic fibrosis in Henan China: a single-center retrospective analysis","volume":"58","author":"Xu","year":"2023","unstructured":"Xu C, Tang Y, Dong L and Shen Y. Clinical and genetic characteristics of children with cystic fibrosis in Henan China: a single-center retrospective analysis. Pediatr Pulmonol 2023; 58: 2865-2870.","journal-title":"Pediatr Pulmonol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13023-022-02279-9","article-title":"Systematic estimation of cystic fibrosis prevalence in Chinese and genetic spectrum comparison to caucasians","volume":"17","author":"Ni","year":"2022","unstructured":"Ni Q, Chen X, Zhang P, Yang L, Lu Y, Xiao F, Wu B, Wang H, Zhou W and Dong X. Systematic estimation of cystic fibrosis prevalence in Chinese and genetic spectrum comparison to caucasians. Orphanet J Rare Dis 2022; 17: 129.","journal-title":"Orphanet J Rare Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fphar.2019.01662","article-title":"CFTR modulators: the changing face of cystic fibrosis in the era of precision medicine","volume":"10","author":"Lopes-Pacheco","year":"2020","unstructured":"Lopes-Pacheco M. CFTR modulators: the changing face of cystic fibrosis in the era of precision medicine. Front Pharmacol 2020; 10: 166.","journal-title":"Front Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Wedenoja S, Ritari J, Partanen J, Kere J and Kolho KL. Enrichment of rare CFTR variants in finnish patients with congenital chloride diarrhea. PLoS One 2025; 20: e0318249.","DOI":"10.1371\/journal.pone.0318249"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"7254391","DOI":"10.1155\/2021\/7254391","article-title":"Analysis of clinical manifestations, imaging features, and gene mutation characteristics of 6 children with cystic fibrosis in China","volume":"2021","author":"Chu","year":"2021","unstructured":"Chu Y, Shuai J, Huang K, Liu J, Lv W and Li B. Analysis of clinical manifestations, imaging features, and gene mutation characteristics of 6 children with cystic fibrosis in China. Evid Based Complement Alternat Med 2021; 2021: 7254391.","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","unstructured":"Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-73.","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1021\/acs.jmedchem.4c02547","article-title":"Discovery and development of CFTR modulators for the treatment of cystic fibrosis","volume":"68","author":"Wang","year":"2025","unstructured":"Wang X, Tse C and Singh A. Discovery and development of CFTR modulators for the treatment of cystic fibrosis. J Med Chem 2025; 68: 2255-2300.","journal-title":"J Med Chem"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41424-018-0069-5","article-title":"SPINK1, PRSS1, CTRC, and CFTR genotypes influence disease onset and clinical outcomes in chronic pancreatitis","volume":"9","author":"WB","year":"2018","unstructured":"Zou WB, Tang XY, Zhou DZ, Qian YY, Hu LH, Yu FF, Yu D, Wu H, Deng SJ, Lin JH, Zhao AJ, Zhao ZH, Wu HY, Zhu JH, Qian W, Wang L, Xin L, Wang MJ, Wang LJ, Fang X, He L, Masson E, Cooper DN, Férec C, Li ZS, Chen JM and Liao Z. SPINK1, PRSS1, CTRC, and CFTR genotypes influence disease onset and clinical outcomes in chronic pancreatitis. Clin Transl Gastroenterol 2018; 9: 204.","journal-title":"Clin Transl Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1476331","DOI":"10.3389\/fphar.2024.1476331","article-title":"Current landscape of cystic fibrosis gene therapy","volume":"15","author":"LW","year":"2024","unstructured":"Plasschaert LW, MacDonald KD and Moffit JS. Current landscape of cystic fibrosis gene therapy. Front Pharmacol 2024; 15: 1476331.","journal-title":"Front Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Heneghan M, Southern KW, Murphy J, Sinha IP and Nevitt SJ. Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del). Cochrane Database Syst Rev 2023; 11: CD010966.","DOI":"10.1002\/14651858.CD010966.pub4"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13023-022-02279-9","article-title":"Systematic estimation of cystic fibrosis prevalence in Chinese and genetic spectrum comparison to caucasians","volume":"17","author":"Ni","year":"2022","unstructured":"Ni Q, Chen X, Zhang P, Yang L, Lu Y, Xiao F, Wu B, Wang H, Zhou W and Dong X. Systematic estimation of cystic fibrosis prevalence in Chinese and genetic spectrum comparison to caucasians. Orphanet J Rare Dis 2022; 17: 129.","journal-title":"Orphanet J Rare Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/jmg-2022-108501","article-title":"Genetic spectrum of Chinese children with cystic fibrosis: comprehensive data analysis from the main referral centre in China","volume":"60","author":"Shen","year":"2022","unstructured":"Shen Y, Tang X, Chen Q, Xu H, Liu H, Liu J, Yang H, Li H and Zhao S. Genetic spectrum of Chinese children with cystic fibrosis: comprehensive data analysis from the main referral centre in China. J Med Genet 2022; 60: 310-5.","journal-title":"J Med Genet"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-med-042921-021447","article-title":"Cystic fibrosis modulator therapies","volume":"74","author":"Jia","year":"2023","unstructured":"Jia S and Taylor-Cousar JL. Cystic fibrosis modulator therapies. Annu Rev Med 2023; 74: 413-426.","journal-title":"Annu Rev Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2301683","DOI":"10.1183\/13993003.01683-2023","article-title":"F\/HN, a hybrid lentiviral vector for cystic fibrosis gene therapy","volume":"65","author":"Moiseenko","year":"2025","unstructured":"Moiseenko A, Sinadinos A, Sergijenko A, Pineault K, Saleh A, Nekola K, Strang N, Eleftheraki A, Boyd AC, Davies JC, Gill DR, Hyde SC, McLachlan G, Rath T, Rothe M, Schambach A, Hobbie S, Schuler M, Maier U, Thomas MJ, Mennerich D, Schmidt M, Griesenbach U, Alton EWFW and Kreuz S. Pharmacological and pre-clinical safety profile of rSIV.F\/HN, a hybrid lentiviral vector for cystic fibrosis gene therapy. Eur Respir J 2025; 65: 2301683.","journal-title":"Eur Respir J"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1001\/jamaoto.2023.2701","article-title":"Elexacaftor-tezacaftor-ivacaftor therapy for chronic sinus disease in cystic fibrosis","volume":"149","author":"Sheikh","year":"2023","unstructured":"Sheikh S, Ho ML, Eisner M, Gushue C, Paul G, Holtzlander M, Johnson T, McCoy KS and Lind M. Elexacaftor-tezacaftor-ivacaftor therapy for chronic sinus disease in cystic fibrosis. JAMA Otolaryngol Head Neck Surg 2023; 149: 1075-1082.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12866-021-02159-5","article-title":"Azithromycin and the microbiota of cystic fibrosis sputum","volume":"21","author":"Acosta","year":"2021","unstructured":"Acosta N, Thornton CS, Surette MG, Somayaji R, Rossi L, Rabin HR and Parkins MD. Azithromycin and the microbiota of cystic fibrosis sputum. BMC Microbiol 2021; 21: 96.","journal-title":"BMC Microbiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1001\/jama.2023.8120","article-title":"Cystic fibrosis: a review","volume":"329","author":"Ong","year":"2023","unstructured":"Ong T and Ramsey BW. Cystic fibrosis: a review. JAMA 2023; 329: 1859-1871.","journal-title":"JAMA"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/5\/ajtr0162903.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:57:39Z","timestamp":1768978659000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/5\/ajtr0162903.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/enom2926","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}